Exposure to petrol compounds appears to be associated with an increased risk of childhood leukemia, including acute lymphoblastic leukemia (ALL), according to a systematic review published in  Blood and Lymphatic Cancer: Targets and Therapy . Read more: https://www.oncologynurseadvisor.com/news/parent-child-petrol-exposure-higher-childhood-leukemia-risk-treatment/

Timely, developmentally tailored diagnostic disclosure may reduce anxiety and strengthen coping among school-aged children with acute lymphoblastic leukemia (ALL), according to exploratory findings from Taiwan published in Patient Education and Counseling . Read more: https://www.oncologynurseadvisor.com/news/acute-leukemia-child-centered-disclosure-well-being-treatment-risk/

Now, a new study is the first to assess the effect of pesticide exposures on the survival of children with leukemia. The study found a statistically significant link between residential rodenticide exposure and a higher risk in children of death from acute lymphoblastic leukemia (ALL), with about 10% of the exposed children dying within five years of diagnosis. Read more: https://beyondpesticides.org/dailynewsblog/2026/02/pesticide-exposure-again-linked-to-childhood-acute-lym

Nearly a third of families with children receiving chemotherapy for acute lymphoblastic leukemia (ALL) – the most common pediatric cancer – develop serious financial difficulties during their child’s treatment, including losing 25% or more of their household income and struggling to cover the costs of basic living expenses such as housing, food, and utilities. Read more: https://www.eurekalert.org/news-releases/1108761

A new type of cancer cell that “warrants urgent investigation” has been discovered in childhood leukaemia and could impact clinical care. Research into new or repurposed treatments that target this new cell type could give hope to children and families worldwide. Read more: https://www.eurekalert.org/news-releases/1105676

Cancer treatment balances on a razor’s edge. On one side, physicians must use enough of a drug to kill tumor cells effectively. On the other side, a high drug concentration can be harmful to a patient’s normal cells. In children, the difference between the two, called the therapeutic index, is small.  Read more: https://www.stjude.org/research/progress/2025/finding-balance-between-efficacy-and-toxicity-in-pediatric-cancer-treatment.html

A new study led by researchers at the University of Minnesota Medical School has identified genetic factors that may help explain why African American children are less likely to develop acute lymphoblastic leukemia (ALL) but tend to face worse outcomes when they do. Read more: https://twin-cities.umn.edu/news-events/university-minnesota-study-uncovers-new-genetic-factors-childhood-leukemia

The new paper reveals for the first time that these DNA fragments can persist in cancer cells and may drive relapse in patients with...

Chemotherapy resistance is particularly common in what is known as T-ALL, a subtype of ALL. This recent study shows that the origin of...

Planned caesarean births—"C-sections"—slightly raise the risk of some childhood cancers—particularly acute lymphoblastic leukemia (ALL),...